Evaluating a novel smartphone-assisted coping focused intervention for people who experience distressing voices (SAVVy)

Not Applicable

Completed

• Conditions: Mental Disorders; Hearing Voices; Auditory hallucinations; Psychotic Disorders; Mental Health - Psychosis and personality disorders; Mental Health - Schizophrenia; Mental Health - Other mental health disorders

• Registration Number: ACTRN12617000348358
• Lead Sponsor: Swinburne University of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-03-07
• Study Completion: 2018-04-11
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

1. Over the age of 18
2. Sufficient conversational English for meaningful participation in the study
3. Current persisting auditory verbal hallucinations defined by, over the week preceding the baseline assessment, hearing a hallucinated voice or voices on at least four different occasions, AND/OR on one or more occasion and lasting for at least an hour (score of 3 or more on PSYRATS-AH item 2)
4. Experiencing distress due to the voices (score of 1 or more on PSYRATS-AH item 8)
5. Experiencing auditory verbal hallucinations for at least 6 months
6. Willing to use the smartphone app during the trial

Exclusion Criteria

1. Unable to provide informed consent
2. Intellectual disability (Wechsler Test of Adult Reading estimated IQ < 70)
3. Voices occur solely in the context of substance use
4. Initiation of a new antipsychotic medication within the previous eight weeks
5. Too distressed or agitated to take part in the study
6. Current risk of harm to self or others that requires active crisis management

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility: level of engagement with intervention sessions rated by the therapist following each session; number of times the EMI coping strategy reminders are viewed; response rates to EMA items; fidelity to intervention protocol rated by the therapist following each session; study recruitment and retention rates[Recorded throughout the intervention (all treatment group only, except for study recruitment and retention rates) ];Acceptability of different components of SAVVy intervention (one-to-one sessions, smarpthone app, feedback): quantitative acceptability measure designed specifically for this study; qualitative interview designed specifically for this study[Following completion of the intervention - treatment group only ];Psychotic Symptom Rating Scales - Auditory Hallucinations (PSYRATS-AH) - Total Score[Baseline, 8 weeks following baseline ]

Secondary Outcome Measures

Name	Time	Method
Subjective Experience of Psychosis Scale (SEPS) – Negative Impact Subscale[Baseline, 8 weeks following baseline ];Depression, Anxiety Stress Scale-21 (DASS-21)[Baseline, 8 weeks following baseline ]